Profil
Dror Haratz currently works at FutuRx Ltd., as Scientific Advisor.
Mr. Haratz also formerly worked at Vascular Biogenics Ltd., as Chief Executive Officer.
Mr. Haratz received his graduate degree from The Hebrew University Hadassah Medical School.
Aktive Positionen von Dror Haratz
| Unternehmen | Position | Beginn |
|---|---|---|
FutuRx Ltd.
 FutuRx Ltd. Investment ManagersFinance FutuRx Ltd (FutuRx ) is a venture capital firm founded in 2014. The firm is headquartered in Ness Ziona. | Berater | - |
Ehemalige bekannte Positionen von Dror Haratz
| Unternehmen | Position | Ende |
|---|---|---|
| NOTABLE LABS, LTD. | Vorstandsvorsitzender | - |
Ausbildung von Dror Haratz
| The Hebrew University Hadassah Medical School | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
FutuRx Ltd.
FutuRx Ltd. Investment ManagersFinance FutuRx Ltd (FutuRx ) is a venture capital firm founded in 2014. The firm is headquartered in Ness Ziona. | Finance |
Vascular Biogenics Ltd.
 Vascular Biogenics Ltd. BiotechnologyHealth Technology Vascular Biogenics Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of next-generation, targeted medicines for difficult-to-treat medical conditions. Its product candidates are built off of its platform technologies: Vascular Targeting System (VTS), a gene-based technology targeting newly formed blood vessels and Monocyte Targeting Technology (MTT), an antibody-based technology able to specifically inhibit monocyte migration for immune-inflammatory applications. The company was founded by Dror Harats and Jacob George on January 27, 2000 and is headquartered in Modi'in, Israel. | Health Technology |
